Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion type Assertion NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_head.
- NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion description "[HKH40A (RTA 502), an optimized 8-methoxy analog of the unsymmetrical bifunctional antitumor agent WMC79, was found to be potently active against liver cancer cell growth in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_provenance.
- NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion evidence source_evidence_literature NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_provenance.
- NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion SIO_000772 18641988 NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_provenance.
- NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion wasDerivedFrom befree-20150227 NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_provenance.
- NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_assertion wasGeneratedBy ECO_0000203 NP874992.RAVyKjTECfwxsKDVFr8jE8zlcfcvclAnzFLfTr-msEtHg130_provenance.